Research Papers

25 of 209 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Phase II study of apatinib plus exemestane in estrogen receptor-positive, human epidermal growth factor receptor 2-nega…
Tan A; Nong L; Wang H; Jia Y; Zhong W; Qin F; Wang H; Tang J; Liu Y; Lu Y.
Cancer Biol Ther (Unknown)
Published: 2023
3/6 Transparent
Registered
Function of m<sup>5</sup>C RNA methyltransferase NOP2 in high-grade serous ovarian cancer.
Yang S; Zhou D; Zhang C; Xiang J; Xi X.
Cancer Biol Ther (Unknown)
Published: 2023
3/6 Transparent
Data
<i>Ruangan Lidan decoction</i> inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregu…
Si T; Huang L; Liang T; Huang P; Zhang H; Zhang M; Zhou X.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
A study on metabolic characteristics and metabolic markers of gastrointestinal tumors.
Cong S; Bai S; Zhang M; Bi Y; Wang Y; Jin S; He H.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Sinapine thiocyanate exhibited anti-colorectal cancer effects by inhibiting KRT6A/S100A2 axis.
Yang Y; Zeng Z; Li L; Lei S; Wu Y; Chen T; Zhang J.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cerv…
Wu S; Liu L; Xu H; Zhu Q; Tan M.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Transcription factor 3 promotes migration and invasion potential and maintains cancer stemness by activating ID1 expres…
Li ZX; Sun MC; Fang K; Zhao ZY; Leng ZY; Zhang ZH; Xu AP; Chu Y; Zhang L; Lian J; Chen T; Xu MD.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
CircSETD2 inhibits YAP1 by interaction with HuR during breast cancer progression.
Jing L; Yang L; Jianbo C; Yuqiu W; Yehui Z.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence.
Adekolujo OS; Wahab A; Akanbi MO; Oyasiji T; Hrinczenko B; Alese OB.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
The human microbiome and cancer: a diagnostic and therapeutic perspective.
Kandalai S; Li H; Zhang N; Peng H; Zheng Q.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer.
Zheng Y; Wu J; Chen H; Lin D; Chen H; Zheng J; Xia H; Huang L; Zeng C.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Tanshinone I suppresses hepatocellular carcinoma cells growth through targeting DNA double-strand break repair.
Qian Z; Feng N; Geng A.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway.
Liu Y; Yang H.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Reprogramming of VEGF-mediated extracellular matrix changes through autocrine signaling.
Goggins E; Mironchik Y; Kakkad S; Jacob D; Wildes F; Bhujwalla ZM; Krishnamachary B.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1.
Wang P; Sun J; Sun C; Zhao H; Zhang Y; Chen J.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Apicidin confers promising therapeutic effect on acute myeloid leukemia cells via increasing QPCT expression.
Liu L; Liu H; Liu L; Huang Q; Yang C; Cheng P; Ren S; Zhang J; Yu M; Ma X; Song W; Chen L; Zhang H; Chen M; Zhang X.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Targeting crosstalk of STAT3 between tumor-associated M2 macrophages and Tregs in colorectal cancer.
Huang L; Zhao Y; Shan M; Wang S; Chen J; Liu Z; Xu Q.
Cancer Biol Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating t…
Chen H; Wang L; Liu J; Wan Z; Zhou L; Liao H; Wan R.
Cancer Biol Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer.
Jia Q; Liao X; Xu B; Li Y; Liang L.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
PLK4 inhibitor exhibits antitumor effect and synergizes sorafenib via arresting cell cycle and inactivating Wnt/β-caten…
Zhu W; Xie B.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
CX43 down-regulation promotes cell aggressiveness and 5-fluorouracil-resistance by attenuating cell stiffness in colore…
Han Y; Wang H; Chen H; Tan T; Wang Y; Yang H; Ding Y; Wang S.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Genomic profiling, prognosis, and potential interventional targets in young and old patients with cholangiocarcinoma.
Wang J; Shi Y; Chen J; Liu J; Zhao X; Pang J; Sun X; Tian Y; Ou Q; Xia F; Chen Y.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Molecular features, biological behaviors and clinical implications of m<sup>5</sup>C RNA methylation modification regul…
Zhan M; Song H; Tian D; Wen Q; Shi X; Wang Y; Mao X; Wang J.
Cancer Biol Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments.
Xiao L; Liu Y; Chen H; Shen L.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent
Flotillin-1 enhances radioresistance through reducing radiation-induced DNA damage and promoting immune escape via STIN…
Wang Y; Meng L; Meng S; Huang L; Luo S; Wu X; Gong X.
Cancer Biol Ther (Unknown)
Published: 2023
2/6 Transparent